CGC - Canopy Growth Corp


1.06
-0.010   -0.943%

Share volume: 5,136,761
Last Updated: 03-10-2026
Pharmaceutical Products/Medicinal Chemicals: 2.20%

PREVIOUS CLOSE
CHG
CHG%

$1.07
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
58%
Profitability 50%
Dept financing 42%
Liquidity 57%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
-0.93%
1 Month
-0.93%
3 Months
-6.19%
6 Months
-23.74%
1 Year
-3.64%
2 Year
-29.33%
Key data
Stock price
$1.06
P/E Ratio 
0.00
DAY RANGE
$1.05 - $1.10
EPS 
-$1.07
52 WEEK RANGE
$0.77 - $2.38
52 WEEK CHANGE
-$5.36
MARKET CAP 
390.103 M
YIELD 
N/A
SHARES OUTSTANDING 
377.863 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-29-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$7,934,174
AVERAGE 30 VOLUME 
$9,093,379
Company detail
CEO: David E. Klein
Region: US
Website: canopygrowth.com
Employees: 3,150
IPO year: 2014
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Canopy Growth Corporation engages in the production, distribution, and sale of cannabis and hemp-based products. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.

Recent news